EcoDrugPlus

Atp-Binding Cassette Sub-Family C Member 9

Ensembl ID : ENSFHEG00000010958
Gene Symbol: LOC105936109
3 Cross references
233 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSFHEG00000017054
Gene Symbol: ATP1A1
3 Cross references
292 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSFHEG00000010122
Gene Symbol: ATP1B1
3 Cross references
217 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSFHEG00000002791
Gene Symbol: ATP1B2
3 Cross references
197 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSFHEG00000010021
Gene Symbol: ATP1B2
3 Cross references
190 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSFHEG00000000908
Gene Symbol: ATR
3 Cross references
205 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSFHEG00000021376
Gene Symbol: AXL
2 Cross references
188 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSFHEG00000018953
Gene Symbol: BRAF
3 Cross references
220 Possible Orthologues:

B2 Bradykinin Receptor-Like

Ensembl ID : ENSFHEG00000011594
Gene Symbol: LOC105929859
3 Cross references
149 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSFHEG00000016376
Gene Symbol: BCL2
3 Cross references
172 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSFHEG00000014556
Gene Symbol: BCL2L1
3 Cross references
229 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSFHEG00000002488
Gene Symbol: BCL2L1
3 Cross references
216 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).